Ms. Thelma J Parker, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 833 Campbell Hill St Nw # St400, Marietta, GA 30060 Phone: 770-528-0260 Fax: 770-528-0269 |
Carson Cooke Ragan, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 833 Campbell Hill St Nw, Suite 400, Marietta, GA 30060 Phone: 770-528-0260 |
Jennifer Afman, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 699 Church St Ne Ste 220, Marietta, GA 30060 Phone: 770-422-8505 Fax: 678-819-7475 |
Ms. Julie A Porter, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 699 Church St Ne, Suite 500, Marietta, GA 30060 Phone: 770-793-9750 Fax: 770-919-0581 |
Ms. Vivian Masters, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 699 Church St Ne, Suite 500, Marietta, GA 30060 Phone: 770-793-9750 Fax: 770-919-0581 |
Elizabeth R Kirkley, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 699 Church St. Ne, Suite 300, Marietta, GA 30060 Phone: 770-422-8700 Fax: 770-425-7601 |
News Archive
UT Southwestern Medical Center researchers have discovered a protein that guides blood vessel development and eventually might lead to a treatment to keep cancer cells from spreading.
Certified Primary Stroke Centers are three times more likely to administer clot-busting treatment for strokes than non-certified centers, reports a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania.
Are you prepared to go to the gym for one hour, three times a week, for 20 weeks - all in the name of science?
BioTime, Inc. today announced a material transfer agreement (MTA) with the University of California (UC) system to make five research-grade human embryonic stem (hES) cell lines available to UC system researchers. These lines are genetically identical to a bank of GMP-compliant hES cell lines that will be made available to California-based researchers under a recent agreement between BioTime and the California Institute for Regenerative Medicine (CIRM).
Researchers found the addition of thalidomide to topotecan for the treatment of recurrent ovarian cancer significantly increases the response to therapy and the duration of progression free survival without additional toxicity.
› Verified 5 days ago